Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12

AUTHORS

Freek Cox, Eirikur Saeland, Matthijs Baart, Martin Koldijk, Jeroen Tolboom, Liesbeth Dekking, Wouter Koudstaal, Karin Lövgren Bengtsson, Jaap Goudsmit, Katarina Radošević

ABSTRACT

BACKGROUND: Influenza virus infections are responsible for significant morbidity worldwide and therefore it remains a high priority to develop more broadly protective vaccines. Adjuvation of current seasonal influenza vaccines has the potential to achieve this goal. METHODS: To assess the immune potentiating properties of Matrix-M™, mice were immunized with virosomal trivalent seasonal vaccine adjuvated with Matrix-M™. Serum samples were isolated to determine the hemagglutination inhibiting (HAI) antibody titers against vaccine homologous and heterologous strains. Furthermore, we assess whether adjuvation with Matrix-M™ broadens the protective efficacy of the virosomal trivalent seasonal vaccine against vaccine homologous and heterologous influenza viruses. RESULTS: Matrix-M™ adjuvation enhanced HAI antibody titers and protection against vaccine homologous strains. Interestingly, Matrix-M™ adjuvation also resulted in HAI antibody titers against heterologous influenza B strains, but not against the tested influenza A strains. Even though the protection against heterologous influenza A was induced by the adjuvated vaccine, in the absence of HAI titers the protection was accompanied by severe clinical scores and body weight loss. In contrast, in the presence of heterologous HAI titers full protection against the heterologous influenza B strain without any disease symptoms was obtained. CONCLUSION: The results of this study emphasize the promising potential of a Matrix-M™-adjuvated seasonal trivalent virosomal influenza vaccine. Adjuvation of trivalent virosomal vaccine does not only enhance homologous protection, but in addition induces protection against heterologous strains and thus provides overall more potent and broad protective immunity. More... »

PAGES

210

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12985-015-0435-9

DOI

http://dx.doi.org/10.1186/s12985-015-0435-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1017133741

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26643820


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adjuvants, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Weight", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemagglutination Inhibition Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunity, Heterologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza Vaccines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred BALB C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Orthomyxoviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Orthomyxoviridae Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaccines, Virus-Like Particle", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Janssen (Netherlands)", 
          "id": "https://www.grid.ac/institutes/grid.497529.4", 
          "name": [
            "Present Address: Infectious Diseases and Vaccines Therapeutic area, Janssen Research and Development, Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cox", 
        "givenName": "Freek", 
        "id": "sg:person.01177731040.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177731040.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Janssen (Netherlands)", 
          "id": "https://www.grid.ac/institutes/grid.497529.4", 
          "name": [
            "Present Address: Infectious Diseases and Vaccines Therapeutic area, Janssen Research and Development, Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saeland", 
        "givenName": "Eirikur", 
        "id": "sg:person.01204400353.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204400353.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Janssen (Netherlands)", 
          "id": "https://www.grid.ac/institutes/grid.497529.4", 
          "name": [
            "Present Address: Infectious Diseases and Vaccines Therapeutic area, Janssen Research and Development, Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baart", 
        "givenName": "Matthijs", 
        "id": "sg:person.0760312455.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760312455.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Present Address: Janssen Prevention Center, Center of Excellence of Janssen Research & Development, Janssen Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koldijk", 
        "givenName": "Martin", 
        "id": "sg:person.01331341250.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331341250.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Janssen (Netherlands)", 
          "id": "https://www.grid.ac/institutes/grid.497529.4", 
          "name": [
            "Present Address: Infectious Diseases and Vaccines Therapeutic area, Janssen Research and Development, Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tolboom", 
        "givenName": "Jeroen", 
        "id": "sg:person.01371723253.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371723253.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Janssen (Netherlands)", 
          "id": "https://www.grid.ac/institutes/grid.497529.4", 
          "name": [
            "Present Address: Infectious Diseases and Vaccines Therapeutic area, Janssen Research and Development, Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dekking", 
        "givenName": "Liesbeth", 
        "id": "sg:person.01211631714.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211631714.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Present Address: Janssen Prevention Center, Center of Excellence of Janssen Research & Development, Janssen Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koudstaal", 
        "givenName": "Wouter", 
        "id": "sg:person.01174222224.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174222224.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novavax (Sweden)", 
          "id": "https://www.grid.ac/institutes/grid.425310.1", 
          "name": [
            "Present Address: Novavax AB, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "L\u00f6vgren Bengtsson", 
        "givenName": "Karin", 
        "id": "sg:person.01200433425.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200433425.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Present Address: Janssen Prevention Center, Center of Excellence of Janssen Research & Development, Janssen Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goudsmit", 
        "givenName": "Jaap", 
        "id": "sg:person.01213452424.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213452424.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Present Address: Sanofi, Global Biotherapeutics, Vitry-sur-Seine, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rado\u0161evi\u0107", 
        "givenName": "Katarina", 
        "id": "sg:person.01125443554.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125443554.88"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1586/14760584.2013.814822", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001213748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2010.12.125", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001997515"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0001401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002069136"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2015.01.070", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002217776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(07)61297-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002675420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0135723", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002853827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2011.01.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004244956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc1306100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006561043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0042-6822(90)90186-u", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008277666"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2013.01.039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009078098"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/jis330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010252437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1473-3099(11)70295-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011788867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2008.04.071", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015547406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.01939-10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015857689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature11414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015902165", 
          "https://doi.org/10.1038/nature11414"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/290713a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015955022", 
          "https://doi.org/10.1038/290713a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0264-410x(02)00512-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017362230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0264-410x(02)00512-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017362230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/jir191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018482711"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/308457a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019446715", 
          "https://doi.org/10.1038/308457a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/hv.29583", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019596254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.75.1.49", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019881235"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2011.04.094", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020187520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1146/annurev-med-120611-145115", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020615448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/jiu334", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023494772"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.1201574", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024057506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrmicro2613", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024223047", 
          "https://doi.org/10.1038/nrmicro2613"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/cimm.2001.1835", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025060258"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0264-410x(03)00073-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025325259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.175.4.1143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028344978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/hv.8.1.17623", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028420578"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0264-410x(97)00115-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028737721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0b013e31819d6394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029775586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0b013e31819d6394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029775586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0b013e31819d6394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029775586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2008.01.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031425078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0903181106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033034376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2567.2006.02421.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037039152"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/erv.11.25", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038742016"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2011.08.042", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038981193"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1204839", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040878480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2009.02.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042619364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.immuni.2013.09.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044759164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2009.11.068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047941227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1222908", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048660627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2009.04.050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049801409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1750-2659.2011.00256.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051414735"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1742-4933-11-10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053441715", 
          "https://doi.org/10.1186/1742-4933-11-10"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/515285", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058789675"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1171491", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062459980"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.288.5468.1051", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062569403"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077028651", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077740011", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082570135", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12", 
    "datePublishedReg": "2015-12-01", 
    "description": "BACKGROUND: Influenza virus infections are responsible for significant morbidity worldwide and therefore it remains a high priority to develop more broadly protective vaccines. Adjuvation of current seasonal influenza vaccines has the potential to achieve this goal.\nMETHODS: To assess the immune potentiating properties of Matrix-M\u2122, mice were immunized with virosomal trivalent seasonal vaccine adjuvated with Matrix-M\u2122. Serum samples were isolated to determine the hemagglutination inhibiting (HAI) antibody titers against vaccine homologous and heterologous strains. Furthermore, we assess whether adjuvation with Matrix-M\u2122 broadens the protective efficacy of the virosomal trivalent seasonal vaccine against vaccine homologous and heterologous influenza viruses.\nRESULTS: Matrix-M\u2122 adjuvation enhanced HAI antibody titers and protection against vaccine homologous strains. Interestingly, Matrix-M\u2122 adjuvation also resulted in HAI antibody titers against heterologous influenza B strains, but not against the tested influenza A strains. Even though the protection against heterologous influenza A was induced by the adjuvated vaccine, in the absence of HAI titers the protection was accompanied by severe clinical scores and body weight loss. In contrast, in the presence of heterologous HAI titers full protection against the heterologous influenza B strain without any disease symptoms was obtained.\nCONCLUSION: The results of this study emphasize the promising potential of a Matrix-M\u2122-adjuvated seasonal trivalent virosomal influenza vaccine. Adjuvation of trivalent virosomal vaccine does not only enhance homologous protection, but in addition induces protection against heterologous strains and thus provides overall more potent and broad protective immunity.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12985-015-0435-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1034449", 
        "issn": [
          "1743-422X"
        ], 
        "name": "Virology Journal", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "Matrix-M\u2122 adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine", 
    "pagination": "210", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "51a1c3171f12082dfda9072550458ead52d21c53a3bd4f430bc51c6b4e60e7c3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26643820"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101231645"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12985-015-0435-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1017133741"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12985-015-0435-9", 
      "https://app.dimensions.ai/details/publication/pub.1017133741"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T02:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000511.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12985-015-0435-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12985-015-0435-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12985-015-0435-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12985-015-0435-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12985-015-0435-9'


 

This table displays all metadata directly associated to this object as RDF triples.

349 TRIPLES      21 PREDICATES      93 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12985-015-0435-9 schema:about N0853e3c8b2ed4582a652f32fc0b09b3f
2 N3b415ae2fb8d4940a96c5b5b345ed524
3 N40311681848c4d7897298828aecb8f8d
4 N41526369a73943b4b10a4ab2b4e19c21
5 N448071cc5d9b46d3acf7a9cb44fc8eb5
6 N55821f45ae1e46e59b8475fc0580658a
7 N6782c4e0093d44b3b200ab2408da0b16
8 N6c1d7eb5fdb3422db42edd3fc68dc85e
9 N80902245ee294effb3959309adc7cd24
10 Nac5abf688aa54cd3b4e1f731f605fdbc
11 Nb1259848a4454b6096ff509bf34bd474
12 Nc16047d1df4047d691861531fe763998
13 Nee282571da084dc9b9cc78a346ad6291
14 anzsrc-for:11
15 anzsrc-for:1107
16 schema:author N5533dbc1b3e34c429261965725ce7588
17 schema:citation sg:pub.10.1038/290713a0
18 sg:pub.10.1038/308457a0
19 sg:pub.10.1038/nature11414
20 sg:pub.10.1038/nrmicro2613
21 sg:pub.10.1186/1742-4933-11-10
22 https://app.dimensions.ai/details/publication/pub.1077028651
23 https://app.dimensions.ai/details/publication/pub.1077740011
24 https://app.dimensions.ai/details/publication/pub.1082570135
25 https://doi.org/10.1006/cimm.2001.1835
26 https://doi.org/10.1016/0042-6822(90)90186-u
27 https://doi.org/10.1016/j.immuni.2013.09.013
28 https://doi.org/10.1016/j.vaccine.2008.01.019
29 https://doi.org/10.1016/j.vaccine.2008.04.071
30 https://doi.org/10.1016/j.vaccine.2009.02.004
31 https://doi.org/10.1016/j.vaccine.2009.04.050
32 https://doi.org/10.1016/j.vaccine.2009.11.068
33 https://doi.org/10.1016/j.vaccine.2010.12.125
34 https://doi.org/10.1016/j.vaccine.2011.01.011
35 https://doi.org/10.1016/j.vaccine.2011.04.094
36 https://doi.org/10.1016/j.vaccine.2011.08.042
37 https://doi.org/10.1016/j.vaccine.2013.01.039
38 https://doi.org/10.1016/j.vaccine.2015.01.070
39 https://doi.org/10.1016/s0140-6736(07)61297-5
40 https://doi.org/10.1016/s0264-410x(02)00512-1
41 https://doi.org/10.1016/s0264-410x(03)00073-2
42 https://doi.org/10.1016/s0264-410x(97)00115-1
43 https://doi.org/10.1016/s1473-3099(11)70295-x
44 https://doi.org/10.1056/nejmc1306100
45 https://doi.org/10.1073/pnas.0903181106
46 https://doi.org/10.1084/jem.175.4.1143
47 https://doi.org/10.1084/jem.75.1.49
48 https://doi.org/10.1086/515285
49 https://doi.org/10.1093/infdis/jir191
50 https://doi.org/10.1093/infdis/jis330
51 https://doi.org/10.1093/infdis/jiu334
52 https://doi.org/10.1097/inf.0b013e31819d6394
53 https://doi.org/10.1111/j.1365-2567.2006.02421.x
54 https://doi.org/10.1111/j.1750-2659.2011.00256.x
55 https://doi.org/10.1126/science.1171491
56 https://doi.org/10.1126/science.1204839
57 https://doi.org/10.1126/science.1222908
58 https://doi.org/10.1126/science.288.5468.1051
59 https://doi.org/10.1128/jvi.01939-10
60 https://doi.org/10.1146/annurev-med-120611-145115
61 https://doi.org/10.1371/journal.pone.0001401
62 https://doi.org/10.1371/journal.pone.0135723
63 https://doi.org/10.1586/14760584.2013.814822
64 https://doi.org/10.1586/erv.11.25
65 https://doi.org/10.4049/jimmunol.1201574
66 https://doi.org/10.4161/hv.29583
67 https://doi.org/10.4161/hv.8.1.17623
68 schema:datePublished 2015-12
69 schema:datePublishedReg 2015-12-01
70 schema:description BACKGROUND: Influenza virus infections are responsible for significant morbidity worldwide and therefore it remains a high priority to develop more broadly protective vaccines. Adjuvation of current seasonal influenza vaccines has the potential to achieve this goal. METHODS: To assess the immune potentiating properties of Matrix-M™, mice were immunized with virosomal trivalent seasonal vaccine adjuvated with Matrix-M™. Serum samples were isolated to determine the hemagglutination inhibiting (HAI) antibody titers against vaccine homologous and heterologous strains. Furthermore, we assess whether adjuvation with Matrix-M™ broadens the protective efficacy of the virosomal trivalent seasonal vaccine against vaccine homologous and heterologous influenza viruses. RESULTS: Matrix-M™ adjuvation enhanced HAI antibody titers and protection against vaccine homologous strains. Interestingly, Matrix-M™ adjuvation also resulted in HAI antibody titers against heterologous influenza B strains, but not against the tested influenza A strains. Even though the protection against heterologous influenza A was induced by the adjuvated vaccine, in the absence of HAI titers the protection was accompanied by severe clinical scores and body weight loss. In contrast, in the presence of heterologous HAI titers full protection against the heterologous influenza B strain without any disease symptoms was obtained. CONCLUSION: The results of this study emphasize the promising potential of a Matrix-M™-adjuvated seasonal trivalent virosomal influenza vaccine. Adjuvation of trivalent virosomal vaccine does not only enhance homologous protection, but in addition induces protection against heterologous strains and thus provides overall more potent and broad protective immunity.
71 schema:genre research_article
72 schema:inLanguage en
73 schema:isAccessibleForFree true
74 schema:isPartOf N29e86fa1dd3743d89069fda0eadd43e3
75 N373f96b82d0b451580eb1cb62dc8feac
76 sg:journal.1034449
77 schema:name Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
78 schema:pagination 210
79 schema:productId N7fde3415d23249329bc499dc41f94085
80 N955aba0e9b7b489db79e0db224d705b0
81 Nc51713a0a102463c955bafd21d02f3d9
82 Nc912c5041ca04e3db023558d1ab39b59
83 Ne705cb81a21e4ced8c276227bab0c409
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017133741
85 https://doi.org/10.1186/s12985-015-0435-9
86 schema:sdDatePublished 2019-04-11T02:00
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher Nac7f267eff834831ab2a1d65f77645e1
89 schema:url http://link.springer.com/10.1186%2Fs12985-015-0435-9
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N0853e3c8b2ed4582a652f32fc0b09b3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Female
95 rdf:type schema:DefinedTerm
96 N29e86fa1dd3743d89069fda0eadd43e3 schema:volumeNumber 12
97 rdf:type schema:PublicationVolume
98 N373f96b82d0b451580eb1cb62dc8feac schema:issueNumber 1
99 rdf:type schema:PublicationIssue
100 N3b415ae2fb8d4940a96c5b5b345ed524 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Vaccines, Virus-Like Particle
102 rdf:type schema:DefinedTerm
103 N40311681848c4d7897298828aecb8f8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Orthomyxoviridae Infections
105 rdf:type schema:DefinedTerm
106 N41526369a73943b4b10a4ab2b4e19c21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Body Weight
108 rdf:type schema:DefinedTerm
109 N43eb2eabb6f240eab723196bb0d4f3b5 rdf:first sg:person.01174222224.97
110 rdf:rest N4965a27220f149be8c2f7693d11c30cb
111 N448071cc5d9b46d3acf7a9cb44fc8eb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Influenza Vaccines
113 rdf:type schema:DefinedTerm
114 N4965a27220f149be8c2f7693d11c30cb rdf:first sg:person.01200433425.12
115 rdf:rest Na18d91e974f148cc903f8fc2335cf5a8
116 N5533dbc1b3e34c429261965725ce7588 rdf:first sg:person.01177731040.86
117 rdf:rest Nccac868eadca4f57b23d6fa3f83a9df7
118 N55821f45ae1e46e59b8475fc0580658a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Severity of Illness Index
120 rdf:type schema:DefinedTerm
121 N5c2560ee7c9149f6a584e847f48c5c13 rdf:first sg:person.01371723253.12
122 rdf:rest Nf2bd0c5cbbcf47af804be80e0f1d7ef8
123 N6782c4e0093d44b3b200ab2408da0b16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Adjuvants, Immunologic
125 rdf:type schema:DefinedTerm
126 N6c1d7eb5fdb3422db42edd3fc68dc85e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Antibodies, Viral
128 rdf:type schema:DefinedTerm
129 N746100dd65384169be664f2d5a7c1467 schema:name Present Address: Janssen Prevention Center, Center of Excellence of Janssen Research & Development, Janssen Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands
130 rdf:type schema:Organization
131 N799746081a6240ff9f91bf5a406a7bd1 rdf:first sg:person.0760312455.52
132 rdf:rest Nc4dd610f68014573885f253e4f4e0bae
133 N7fde3415d23249329bc499dc41f94085 schema:name nlm_unique_id
134 schema:value 101231645
135 rdf:type schema:PropertyValue
136 N80902245ee294effb3959309adc7cd24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Animals
138 rdf:type schema:DefinedTerm
139 N8629e2b136fb484787618ac107601319 schema:name Present Address: Janssen Prevention Center, Center of Excellence of Janssen Research & Development, Janssen Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands
140 rdf:type schema:Organization
141 N955aba0e9b7b489db79e0db224d705b0 schema:name pubmed_id
142 schema:value 26643820
143 rdf:type schema:PropertyValue
144 Na18d91e974f148cc903f8fc2335cf5a8 rdf:first sg:person.01213452424.71
145 rdf:rest Nb3492f84d9d04d798995e5ad1c30fc2f
146 Nac5abf688aa54cd3b4e1f731f605fdbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Orthomyxoviridae
148 rdf:type schema:DefinedTerm
149 Nac7f267eff834831ab2a1d65f77645e1 schema:name Springer Nature - SN SciGraph project
150 rdf:type schema:Organization
151 Nb1259848a4454b6096ff509bf34bd474 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Hemagglutination Inhibition Tests
153 rdf:type schema:DefinedTerm
154 Nb3492f84d9d04d798995e5ad1c30fc2f rdf:first sg:person.01125443554.88
155 rdf:rest rdf:nil
156 Nc16047d1df4047d691861531fe763998 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Immunity, Heterologous
158 rdf:type schema:DefinedTerm
159 Nc4dd610f68014573885f253e4f4e0bae rdf:first sg:person.01331341250.84
160 rdf:rest N5c2560ee7c9149f6a584e847f48c5c13
161 Nc501a8f502f24401abd3d7666d02e481 schema:name Present Address: Sanofi, Global Biotherapeutics, Vitry-sur-Seine, France
162 rdf:type schema:Organization
163 Nc51713a0a102463c955bafd21d02f3d9 schema:name doi
164 schema:value 10.1186/s12985-015-0435-9
165 rdf:type schema:PropertyValue
166 Nc912c5041ca04e3db023558d1ab39b59 schema:name dimensions_id
167 schema:value pub.1017133741
168 rdf:type schema:PropertyValue
169 Nccac868eadca4f57b23d6fa3f83a9df7 rdf:first sg:person.01204400353.14
170 rdf:rest N799746081a6240ff9f91bf5a406a7bd1
171 Nd5d1a6b141b74263b86e0cec12db23ae schema:name Present Address: Janssen Prevention Center, Center of Excellence of Janssen Research & Development, Janssen Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands
172 rdf:type schema:Organization
173 Ne705cb81a21e4ced8c276227bab0c409 schema:name readcube_id
174 schema:value 51a1c3171f12082dfda9072550458ead52d21c53a3bd4f430bc51c6b4e60e7c3
175 rdf:type schema:PropertyValue
176 Nee282571da084dc9b9cc78a346ad6291 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Mice, Inbred BALB C
178 rdf:type schema:DefinedTerm
179 Nf2bd0c5cbbcf47af804be80e0f1d7ef8 rdf:first sg:person.01211631714.00
180 rdf:rest N43eb2eabb6f240eab723196bb0d4f3b5
181 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
182 schema:name Medical and Health Sciences
183 rdf:type schema:DefinedTerm
184 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
185 schema:name Immunology
186 rdf:type schema:DefinedTerm
187 sg:journal.1034449 schema:issn 1743-422X
188 schema:name Virology Journal
189 rdf:type schema:Periodical
190 sg:person.01125443554.88 schema:affiliation Nc501a8f502f24401abd3d7666d02e481
191 schema:familyName Radošević
192 schema:givenName Katarina
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125443554.88
194 rdf:type schema:Person
195 sg:person.01174222224.97 schema:affiliation Nd5d1a6b141b74263b86e0cec12db23ae
196 schema:familyName Koudstaal
197 schema:givenName Wouter
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174222224.97
199 rdf:type schema:Person
200 sg:person.01177731040.86 schema:affiliation https://www.grid.ac/institutes/grid.497529.4
201 schema:familyName Cox
202 schema:givenName Freek
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177731040.86
204 rdf:type schema:Person
205 sg:person.01200433425.12 schema:affiliation https://www.grid.ac/institutes/grid.425310.1
206 schema:familyName Lövgren Bengtsson
207 schema:givenName Karin
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200433425.12
209 rdf:type schema:Person
210 sg:person.01204400353.14 schema:affiliation https://www.grid.ac/institutes/grid.497529.4
211 schema:familyName Saeland
212 schema:givenName Eirikur
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204400353.14
214 rdf:type schema:Person
215 sg:person.01211631714.00 schema:affiliation https://www.grid.ac/institutes/grid.497529.4
216 schema:familyName Dekking
217 schema:givenName Liesbeth
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211631714.00
219 rdf:type schema:Person
220 sg:person.01213452424.71 schema:affiliation N8629e2b136fb484787618ac107601319
221 schema:familyName Goudsmit
222 schema:givenName Jaap
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213452424.71
224 rdf:type schema:Person
225 sg:person.01331341250.84 schema:affiliation N746100dd65384169be664f2d5a7c1467
226 schema:familyName Koldijk
227 schema:givenName Martin
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331341250.84
229 rdf:type schema:Person
230 sg:person.01371723253.12 schema:affiliation https://www.grid.ac/institutes/grid.497529.4
231 schema:familyName Tolboom
232 schema:givenName Jeroen
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371723253.12
234 rdf:type schema:Person
235 sg:person.0760312455.52 schema:affiliation https://www.grid.ac/institutes/grid.497529.4
236 schema:familyName Baart
237 schema:givenName Matthijs
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760312455.52
239 rdf:type schema:Person
240 sg:pub.10.1038/290713a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015955022
241 https://doi.org/10.1038/290713a0
242 rdf:type schema:CreativeWork
243 sg:pub.10.1038/308457a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019446715
244 https://doi.org/10.1038/308457a0
245 rdf:type schema:CreativeWork
246 sg:pub.10.1038/nature11414 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015902165
247 https://doi.org/10.1038/nature11414
248 rdf:type schema:CreativeWork
249 sg:pub.10.1038/nrmicro2613 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024223047
250 https://doi.org/10.1038/nrmicro2613
251 rdf:type schema:CreativeWork
252 sg:pub.10.1186/1742-4933-11-10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053441715
253 https://doi.org/10.1186/1742-4933-11-10
254 rdf:type schema:CreativeWork
255 https://app.dimensions.ai/details/publication/pub.1077028651 schema:CreativeWork
256 https://app.dimensions.ai/details/publication/pub.1077740011 schema:CreativeWork
257 https://app.dimensions.ai/details/publication/pub.1082570135 schema:CreativeWork
258 https://doi.org/10.1006/cimm.2001.1835 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025060258
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1016/0042-6822(90)90186-u schema:sameAs https://app.dimensions.ai/details/publication/pub.1008277666
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1016/j.immuni.2013.09.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044759164
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1016/j.vaccine.2008.01.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031425078
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1016/j.vaccine.2008.04.071 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015547406
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1016/j.vaccine.2009.02.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042619364
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1016/j.vaccine.2009.04.050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049801409
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1016/j.vaccine.2009.11.068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047941227
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1016/j.vaccine.2010.12.125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001997515
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1016/j.vaccine.2011.01.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004244956
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1016/j.vaccine.2011.04.094 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020187520
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1016/j.vaccine.2011.08.042 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038981193
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1016/j.vaccine.2013.01.039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009078098
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1016/j.vaccine.2015.01.070 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002217776
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/s0140-6736(07)61297-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002675420
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/s0264-410x(02)00512-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017362230
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1016/s0264-410x(03)00073-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025325259
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1016/s0264-410x(97)00115-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028737721
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1016/s1473-3099(11)70295-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011788867
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1056/nejmc1306100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006561043
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1073/pnas.0903181106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033034376
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1084/jem.175.4.1143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028344978
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1084/jem.75.1.49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019881235
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1086/515285 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058789675
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1093/infdis/jir191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018482711
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1093/infdis/jis330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010252437
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1093/infdis/jiu334 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023494772
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1097/inf.0b013e31819d6394 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029775586
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1111/j.1365-2567.2006.02421.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037039152
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1111/j.1750-2659.2011.00256.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051414735
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1126/science.1171491 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062459980
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1126/science.1204839 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040878480
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1126/science.1222908 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048660627
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1126/science.288.5468.1051 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062569403
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1128/jvi.01939-10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015857689
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1146/annurev-med-120611-145115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020615448
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1371/journal.pone.0001401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002069136
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1371/journal.pone.0135723 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002853827
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1586/14760584.2013.814822 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001213748
335 rdf:type schema:CreativeWork
336 https://doi.org/10.1586/erv.11.25 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038742016
337 rdf:type schema:CreativeWork
338 https://doi.org/10.4049/jimmunol.1201574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024057506
339 rdf:type schema:CreativeWork
340 https://doi.org/10.4161/hv.29583 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019596254
341 rdf:type schema:CreativeWork
342 https://doi.org/10.4161/hv.8.1.17623 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028420578
343 rdf:type schema:CreativeWork
344 https://www.grid.ac/institutes/grid.425310.1 schema:alternateName Novavax (Sweden)
345 schema:name Present Address: Novavax AB, Uppsala, Sweden
346 rdf:type schema:Organization
347 https://www.grid.ac/institutes/grid.497529.4 schema:alternateName Janssen (Netherlands)
348 schema:name Present Address: Infectious Diseases and Vaccines Therapeutic area, Janssen Research and Development, Pharmaceutical companies of Johnson and Johnson, Leiden, The Netherlands
349 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...